AAAAAA
Results: 1-25/55
Authors:
Gupta, AK
Lambert, J
Revuz, J
Shear, N
Citation: Ak. Gupta et al., Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses, EUR J DERM, 11(1), 2001, pp. 6-10
Authors:
Revuz, J
Citation: J. Revuz, New advances in severe adverse drug reactions, DERM CLIN, 19(4), 2001, pp. 697
Authors:
Revuz, J
Citation: J. Revuz, To reform huriet's law, ANN DER VEN, 128(8-9), 2001, pp. 853-855
Authors:
Crickx, B
Grosshans, E
Bagot, M
Roujeau, JC
Revuz, J
Faure, M
Citation: B. Crickx et al., Reform of the 2nd part of the 2nd cycle of medical teaching in France, ANN DER VEN, 128(8-9), 2001, pp. 964-967
Authors:
Estines, O
Revuz, J
Wolkenstein, P
Bressieux, JM
Roujeau, JC
Cosnes, A
Citation: O. Estines et al., Sarcoidosis: thalidomide treatment in ten patients, ANN DER VEN, 128(5), 2001, pp. 611-613
Authors:
Mahe, E
Zeller, J
Wechsler, J
Wolkenstein, P
Revuz, J
Citation: E. Mahe et al., Large hairy pigmented spots in neurofibromatosis type I: an atypical aspect of neurofibromas., ANN DER VEN, 128(5), 2001, pp. 619-621
Authors:
Assier-Bonnet, H
Slimani, S
Revuz, J
Citation: H. Assier-bonnet et al., No interaction between aluminium occlusive chambers and thiomersal, ANN DER VEN, 128(10), 2001, pp. 1025-1026
Authors:
Moreno, JC
Mathoret, C
Lantieri, L
Zeller, J
Revuz, J
Wolkenstein, P
Citation: Jc. Moreno et al., Carbon dioxide laser for removal of multiple cutaneous neurofibromas, BR J DERM, 144(5), 2001, pp. 1096-1098
Authors:
Chosidow, O
Drouault, Y
Leconte-Veyriac, F
Aymard, M
Ortonne, JP
Pouget, F
Revuz, J
Decazes, JM
Malkin, JE
Citation: O. Chosidow et al., Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial, BR J DERM, 144(4), 2001, pp. 818-824
Authors:
Leroy, K
Dumas, V
Martin-Garcia, N
Falzone, MC
Voisin, MC
Wechsler, J
Revuz, J
Creange, A
Levy, E
Lantieri, L
Zeller, J
Wolkenstein, P
Citation: K. Leroy et al., Malignant peripheral nerve sheath tumors associated with neurofibromatosistype 1 - A clinicopathologic and molecular study of 17 patients, ARCH DERMAT, 137(7), 2001, pp. 908-913
Authors:
Wolkenstein, P
Mitrofanoff, M
Lantieri, L
Zeller, J
Wechsler, J
Boui, M
Revuz, J
Mansat, E
Stalder, JF
Citation: P. Wolkenstein et al., Bleeding: A complication of neurofibromatosis 1 tumors, ARCH DERMAT, 137(2), 2001, pp. 233-234
Authors:
Wolkenstein, P
Zeller, J
Revuz, J
Ecosse, E
Leplege, A
Citation: P. Wolkenstein et al., Quality-of-life impairment in neurofibromatosis type 1 - A cross-sectionalstudy of 128 cases, ARCH DERMAT, 137(11), 2001, pp. 1421-1425
Utility of HLA typing in the differential diagnosis of severe aphthosis and Behcet's disease - Reply
Authors:
Revuz, J
Verpilleux, MP
Bastuji-Garin, S
Citation: J. Revuz et al., Utility of HLA typing in the differential diagnosis of severe aphthosis and Behcet's disease - Reply, DERMATOLOGY, 201(3), 2000, pp. 281-281
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissol, D
Dore, JF
Garbay, JR
Vilmer, C
Borel, C
Boulier, N
Cabarrot, E
Carrie, C
Chevreau, C
de Cislain, C
Delaunay, MM
Depardieu, C
Dubois, JB
Escande, MC
Fraisse, J
Parache, RM
Philip, T
Ravaud, A
Sancho-Garnier, H
Spatz, A
Autier, P
Bonnetblanc, JM
de Raucourt, S
Dreno, B
Gouttebel, MC
Grange, F
Guillot, B
Khayat, D
Lehmann, M
Leroy, D
Regal, R
Revuz, J
Saiag, P
Schmutz, JL
Truchetet, F
Vuillemin, P
Citation: S. Negrier et al., Standards, options and guidelines for caring for patients with cutaneous melanomas, PRESSE MED, 29(23), 2000, pp. 1317-1326
Authors:
Wolkenstein, P
Revuz, J
Citation: P. Wolkenstein et J. Revuz, Toxic epidermal necrolysis, DERM CLIN, 18(3), 2000, pp. 485
Authors:
Bouloc, A
Boulland, ML
Geissmann, F
Fraitag, S
Andry, P
Teillac, D
Bensussan, A
Revuz, J
Boumsell, L
Wechsler, J
Bagot, M
Citation: A. Bouloc et al., CD101 expression by Langerhans cell histiocytosis cells, HISTOPATHOL, 36(3), 2000, pp. 229-232
Authors:
Bouloc, A
Joly, P
Saint-Leger, E
Wechsler, J
Roujeau, JC
Revuz, J
Citation: A. Bouloc et al., Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3, J AM ACAD D, 43(4), 2000, pp. 714-717
Authors:
Revuz, J
Chosidow, O
Mole, B
Namias, A
Begaud, B
Laffon, M
Fusciardi, J
Reuter, G
Citation: J. Revuz et al., Esthetics and mortal risk, ANN DER VEN, 127(8-9), 2000, pp. 778-783
Authors:
Laffitte, E
Revuz, J
Citation: E. Laffitte et J. Revuz, Thalidomide, ANN DER VEN, 127(6-7), 2000, pp. 603-613
Authors:
Bernard, P
Revuz, J
Citation: P. Bernard et J. Revuz, What's the true value of a consensus conference?, ANN DER VEN, 127(3), 2000, pp. 253-254
Authors:
Revuz, J
Citation: J. Revuz, Response to the anatomopathologists, ANN DER VEN, 127(3), 2000, pp. 302-302
Authors:
Revuz, J
Citation: J. Revuz, Quality of life index in dermatology, ANN DER VEN, 127, 2000, pp. 7-8
Authors:
Revuz, J
Citation: J. Revuz, Male pattern baldness and quality of life, ANN DER VEN, 127, 2000, pp. 15-16
Authors:
Revuz, J
Citation: J. Revuz, G. Orth, D. Dompmartin, P. Agache, M. Faure, O. Croissant: "The plurality of human papillomaviruses" - Comment, ANN DER VEN, 127(11), 2000, pp. 1029-1036
Authors:
Revuz, J
Citation: J. Revuz, Isotretinoin and pregnancy, ANN DER VEN, 127(10), 2000, pp. 797-798